Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | More
or

Biotech Vaneck ETF (BBH)

Biotech Vaneck ETF (BBH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fund Basics

See More
  • Fund Family Van Eck Associates
  • Assets Under Management 525,886,800
  • Market Capitalization, $K 525,887
  • Shares Outstanding, K 3,047
  • 60-Month Beta 1.13
  • Price/Earnings ttm 22.86
  • Annual Dividend & Yield 0.47 (0.27%)
  • Most Recent Dividend 0.472 on 12/23/19
  • Management Fee 0.35%
  • Sectors:

    ETFs - Biotech

Price Performance

See More
Period Period Low Period High Performance
1-Month
157.65 +8.49%
on 06/17/20
174.47 -1.97%
on 07/15/20
+13.36 (+8.47%)
since 06/16/20
3-Month
144.71 +18.19%
on 05/01/20
174.47 -1.97%
on 07/15/20
+28.16 (+19.71%)
since 04/16/20
52-Week
112.03 +52.66%
on 03/23/20
174.47 -1.97%
on 07/15/20
+45.89 (+36.67%)
since 07/16/19

Most Recent Stories

More News
Moderna Inches Closer to Coronavirus Vaccine: ETFs to Shine

Moderna plans to begin the Phase 3 study of mRNA-1273 this month.

PFE : 35.35 (-1.04%)
MRNA : 81.35 (+1.41%)
IBB : 141.01 (-1.13%)
CNCR : 27.03 (-1.82%)
XBI : 115.85 (-1.19%)
BBH : 171.03 (-1.00%)
FBT : 174.47 (-0.90%)
BTEC : 46.24 (-2.41%)
IDNA : 39.70 (-1.29%)
GERM : 31.41 (-0.60%)
How to Tap Red-Hot Moderna Stock With ETFs

Moderna shares have surged more than 280% so far this year on the positive development of coronavirus vaccine.

MRNA : 81.35 (+1.41%)
IBB : 141.01 (-1.13%)
CNCR : 27.03 (-1.82%)
XBI : 115.85 (-1.19%)
BBH : 171.03 (-1.00%)
BTEC : 46.24 (-2.41%)
IDNA : 39.70 (-1.29%)
GERM : 31.41 (-0.60%)
Expect Further Rally in Nasdaq-100 ETFs as Moderna Joins

Moderna shares have gained a whopping 283.6% this year due to successful early-stage clinical trials for COVID-19 vaccine, winning a place on the Nasdaq-100 with the company's sheer success.

MRNA : 81.35 (+1.41%)
QQQ : 258.89 (-0.77%)
BBH : 171.03 (-1.00%)
QQEW : 82.37 (-0.68%)
TQQQ : 111.23 (-2.22%)
IPO : 42.46 (-1.67%)
BTEC : 46.24 (-2.41%)
GERM : 31.41 (-0.60%)
Biotech ETFs to Shine on Pfizer's Coronavirus Vaccine Progress

Two out of four of Pfizer's coronavirus vaccine candidates, BNT162b1 and BNT162b2, have been granted the 'fast track' designation by the FDA.

JNJ : 147.64 (-0.42%)
AZN : 56.98 (-1.76%)
PFE : 35.35 (-1.04%)
MRNA : 81.35 (+1.41%)
IBB : 141.01 (-1.13%)
XBI : 115.85 (-1.19%)
BBH : 171.03 (-1.00%)
FBT : 174.47 (-0.90%)
ARKG : 56.06 (-2.64%)
Biotech ETFs to Gain as Coronavirus Vaccine Hopes Strengthen

As the coronavirus outbreak continues to aggravate, investors are eyeing developments in vaccine or treatments to combat the pandemic.

JNJ : 147.64 (-0.42%)
AZN : 56.98 (-1.76%)
PFE : 35.35 (-1.04%)
MRNA : 81.35 (+1.41%)
IBB : 141.01 (-1.13%)
XBI : 115.85 (-1.19%)
BBH : 171.03 (-1.00%)
FBT : 174.47 (-0.90%)
ARKG : 56.06 (-2.64%)
Moderna a Step Closer to Coronavirus Vaccine: ETFs to Gain

Moderna informs that the final-stage trial's primary aim will be to prevent the spread of coronavirus.

JNJ : 147.64 (-0.42%)
AZN : 56.98 (-1.76%)
MRNA : 81.35 (+1.41%)
IBB : 141.01 (-1.13%)
CNCR : 27.03 (-1.82%)
XBI : 115.85 (-1.19%)
BBH : 171.03 (-1.00%)
IDNA : 39.70 (-1.29%)
How Are Biotech ETFs Reacting to Coronavirus Treatment News?

Here we take a look at how the latest updates on drugs, antibody therapies and vaccines targeted at winning the coronavirus battle can affect biotech ETFs.

GILD : 76.39 (-0.34%)
LLY : 163.86 (-0.96%)
IBB : 141.01 (-1.13%)
XBI : 115.85 (-1.19%)
BBH : 171.03 (-1.00%)
FBT : 174.47 (-0.90%)
ARKG : 56.06 (-2.64%)
These ETF Areas Make Great Investment Choices in June

Here we highlight some ETF areas that will make interesting investment options for investors amid the coronavirus crisis.

IBB : 141.01 (-1.13%)
XBI : 115.85 (-1.19%)
BBH : 171.03 (-1.00%)
JETS : 16.67 (-3.31%)
IBUY : 76.30 (-0.57%)
BOTZ : 24.87 (-1.50%)
SKYY : 74.05 (-1.13%)
CLIX : 78.83 (-0.64%)
IRBO : 30.61 (-1.23%)
CLOU : 21.55 (-1.73%)
Biotech ETFs Soaring on COVID-19 Vaccine Progress

Novavax's latest progress in the Covid-19 vaccine development brings optimism to the Wall Street.

JNJ : 147.64 (-0.42%)
AZN : 56.98 (-1.76%)
MRNA : 81.35 (+1.41%)
NVAX : 116.63 (+4.93%)
IBB : 141.01 (-1.13%)
XBI : 115.85 (-1.19%)
BBH : 171.03 (-1.00%)
FBT : 174.47 (-0.90%)
ARKG : 56.06 (-2.64%)
Race for Coronavirus Vaccine Heats Up: Biotech ETFs to Gain

The COVID-19 pandemic has kept biotech players all over the world on their toes for a vaccine. This new opportunity has made the sector the most attractive one to investors.

JNJ : 147.64 (-0.42%)
SNY : 52.84 (-0.81%)
PFE : 35.35 (-1.04%)
MRK : 78.97 (-0.59%)
MRNA : 81.35 (+1.41%)
GSK : 41.32 (-1.50%)
NVAX : 116.63 (+4.93%)
IBB : 141.01 (-1.13%)
XBI : 115.85 (-1.19%)
BBH : 171.03 (-1.00%)
BBC : 42.12 (-2.59%)
ARKG : 56.06 (-2.64%)
BNTX : 75.67 (-2.99%)
GNOM : 18.38 (-1.71%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 100% Buy with a Strongest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Trade BBH with:

Fund Summary

The VanEck Vectors Biotech ETF seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS US Listed Biotech 25 Index, which is intended to track the overall performance of companies involved in the development and production, marketing and sales of...

See More

Key Turning Points

2nd Resistance Point 176.33
1st Resistance Point 174.54
Last Price 171.03
1st Support Level 170.90
2nd Support Level 169.05

See More

52-Week High 174.47
Last Price 171.03
Fibonacci 61.8% 150.62
Fibonacci 50% 143.25
Fibonacci 38.2% 135.88
52-Week Low 112.03

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar